The Regulatory Challenge of Biotechnology: Human Genetics, Food and Patents. . . a compilation of 12 invaluable contributions on this issue by internationally known experts in their respective fields. . . a valuable resource for academic professionals, policy makers and legislators, advocacy groups and scholars in legal and deve |
From inside the book
Results 1-5 of 63
Page viii
He was previously Foundation Director of the Australian Centre for Environmental Law (1992–2001), Visiting Research Fellow at the London School of Economics (2001), Visiting and Senior Fulbright Scholar at viii Contributors.
He was previously Foundation Director of the Australian Centre for Environmental Law (1992–2001), Visiting Research Fellow at the London School of Economics (2001), Visiting and Senior Fulbright Scholar at viii Contributors.
Page ix
School of Economics (2001), Visiting and Senior Fulbright Scholar at the Center for the Study of Law and Society, University of California, Berkeley and Research Fellow at the American Bar Foundation, Chicago.He has also been consultant ...
School of Economics (2001), Visiting and Senior Fulbright Scholar at the Center for the Study of Law and Society, University of California, Berkeley and Research Fellow at the American Bar Foundation, Chicago.He has also been consultant ...
Page xi
... Cells Derived from Them', in The Ethics of Patenting Human Genes and Stem Cells, Copenhagen: Council of Ethics and (2005), 'Protecting and Sharing Biodiversity and Traditional Knowledge: Holder and User Tools', Ecological Economics.
... Cells Derived from Them', in The Ethics of Patenting Human Genes and Stem Cells, Copenhagen: Council of Ethics and (2005), 'Protecting and Sharing Biodiversity and Traditional Knowledge: Holder and User Tools', Ecological Economics.
Page xiv
... on the contrary, infers from the fact that biotechnology policy places so much confidence in the state to exert control over social and economic actors that biotechnology policy has not yet matured into a field of regulation at all.
... on the contrary, infers from the fact that biotechnology policy places so much confidence in the state to exert control over social and economic actors that biotechnology policy has not yet matured into a field of regulation at all.
Page xvii
Economic aspects explicitly fall within Member States' reserved powers, but in practice this may prove neither a clear nor sufficient basis for Member States to adopt appropriate coexistence measures. All in all, there is every reason ...
Economic aspects explicitly fall within Member States' reserved powers, but in practice this may prove neither a clear nor sufficient basis for Member States to adopt appropriate coexistence measures. All in all, there is every reason ...
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
| 3 | |
2 Rethinking regulatory governance for the age of biotechnology | 19 |
PART II Regulating human genetics | 37 |
GMOs biosafety and environmental decisionmaking | 95 |
the two faces of the precautionary principle | 118 |
three levels three issues | 139 |
issues of EC law | 156 |
plant genetic resources and agricultural trade reform | 174 |
PART IV Regulating biotechnology through the patent system | 201 |
10 Should we regulate biotechnology through the patent system? The case of terminator technology | 203 |
exploring the interface between regulation and innovation regimes | 214 |
measures to restore trust in the patent system | 238 |
Index | 257 |
Other editions - View all
The Regulatory Challenge of Biotechnology: Human Genetics, Food and Patents Han Somsen No preview available - 2007 |
Common terms and phrases
adopted affect agricultural application Article authorization benefits Bioethics biotech biotechnology biotechnology regulation Brownsword Cartagena cell research coexistence measures commercial Commission’s Community concerns Council crop germplasm decision Deliberate Release Directive developing countries different difficult draft economic effects embryos environment environmental ethical European Commission example farmers field first Food and Feed gene genetic testing Genetically Modified Organisms global GM crops GM food GMCs GMOs human genetics industry influence informed consent Intellectual Property Intellectual Property Rights International inventions issues legislation license maize Member moral norms notification offer Office Official Overwalle patent law patent system PGRFA plant genetic resources political potential practice precautionary principle protection Protocol reflect regime regu regulatory risk assessment scientific seed significant social society specific SPS Agreement standards Stem Cell sufficient terminator technology therapeutic cloning trade transgenic Treaty World Trade Organization
Popular passages
Page 134 - In order to protect the environment, the precautionary approach shall be widely applied by States according to their capabilities. Where there are threats of serious or irreversible damage, lack of full scientific certainty shall not be used as a reason for postponing cost-effective measures to prevent environmental degradation.
Page 108 - The products of the territory of any contracting party imported into the territory of any other contracting party shall be accorded treatment no less favourable than that accorded to like products of national origin in respect of all laws, regulations and requirements affecting their internal sale, offering for sale, purchase, transportation, distribution or use.
Page 236 - April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (the Clinical Trials Directive).
Page 213 - States became a member of the International Union for the Pro-tection of New Varieties of Plants (UPOV).
Page 73 - Tests which are predictive of genetic diseases or which serve either to identify the subject äs a carrier of a gene responsible for a disease or to detect a genetic predisposition or susceptibility to a disease may be performed only for health purposes or for scientific research linked to health purposes, and subject to appropriate genetic counselling.
Page 134 - Lack of scientific certainty due to insufficient relevant scientific information and knowledge regarding the extent of the potential adverse effects of a living modified organism on the conservation and sustainable use of biological diversity in the Party of import, taking also into account risks to human health, shall not prevent that Party from taking a decision...
Page 194 - Xn + n) which all enjoy in common in the sense that each individual's consumption of such a good leads to no subtraction from any other individual's consumption of that good...
Page 252 - Disposal of a removed part of the human body When in the course of an intervention any part of a human body is removed, it may be stored and used for a purpose other than that for which it was removed only if this is done in conformity with appropriate information and consent procedures.
Page 110 - Members shall ensure that any sanitary or phytosanitary measure is applied only to the extent necessary to protect human, animal or plant life or health...
Bibliographic information
| Title | The Regulatory Challenge of Biotechnology: Human Genetics, Food and Patents Biotechnology regulation series |
| Editor | Han Somsen |
| Publisher | Edward Elgar Publishing, 2007 |
| ISBN | 1847204414, 9781847204417 |
| Length | 290 pages |
| Export Citation | BiBTeX EndNote RefMan |